MX345344B - Sistema terapéutico transdérmico para la administración de una sustancia activa. - Google Patents
Sistema terapéutico transdérmico para la administración de una sustancia activa.Info
- Publication number
- MX345344B MX345344B MX2013005581A MX2013005581A MX345344B MX 345344 B MX345344 B MX 345344B MX 2013005581 A MX2013005581 A MX 2013005581A MX 2013005581 A MX2013005581 A MX 2013005581A MX 345344 B MX345344 B MX 345344B
- Authority
- MX
- Mexico
- Prior art keywords
- active substance
- administering
- transdermal therapeutic
- therapeutic system
- layer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere a un sistema terapéutico transdérmico para la administración de una sustancia activa a través de la piel, dicho sistema siendo adecuado para un período de aplicación de por lo menos tres días,, que comprende las capas dispuestas en el orden siguiente con respecto una a la otra: a) una capa de cubierta, b) una capa de principio activo que comprende una matriz polimérica que contiene la sustancia activa, c) una capa adhesiva que comprende un adhesivo de contacto, que consiste en una mezcla de uno o más poliisobutilenos y uno o más polibutenos, y d) una capa de desprendimiento.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10194968.3A EP2468274B1 (de) | 2010-12-14 | 2010-12-14 | Transdermales therapeutisches System zur Verabreichung eines Wirkstoffs |
| PCT/EP2011/072812 WO2012080365A1 (de) | 2010-12-14 | 2011-12-14 | Transdermales therapeutisches system zur verabreichung eines wirkstoffs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2013005581A MX2013005581A (es) | 2013-08-26 |
| MX345344B true MX345344B (es) | 2017-01-26 |
Family
ID=43836835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013005581A MX345344B (es) | 2010-12-14 | 2011-12-14 | Sistema terapéutico transdérmico para la administración de una sustancia activa. |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US10660863B2 (es) |
| EP (2) | EP2468274B1 (es) |
| JP (1) | JP6043296B2 (es) |
| KR (1) | KR101842309B1 (es) |
| CN (3) | CN113244199A (es) |
| AU (2) | AU2011343363B2 (es) |
| BR (1) | BR112013014616B1 (es) |
| CA (2) | CA2817461C (es) |
| CY (2) | CY1116638T1 (es) |
| DK (2) | DK2468274T3 (es) |
| EA (1) | EA026520B1 (es) |
| ES (2) | ES2545094T3 (es) |
| HK (1) | HK1243336A1 (es) |
| HR (2) | HRP20150881T1 (es) |
| HU (2) | HUE027916T2 (es) |
| LT (1) | LT2651410T (es) |
| MX (1) | MX345344B (es) |
| MY (1) | MY183873A (es) |
| PL (2) | PL2468274T3 (es) |
| PT (2) | PT2468274E (es) |
| RS (2) | RS54173B1 (es) |
| SI (2) | SI2468274T1 (es) |
| SM (1) | SMT201500184B (es) |
| WO (1) | WO2012080365A1 (es) |
| ZA (1) | ZA201303965B (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102012000369A1 (de) * | 2012-01-11 | 2013-07-11 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Transdermales therapeutisches System mit Cholinesterase-Hemmer |
| DE102012016317A1 (de) * | 2012-08-14 | 2014-02-20 | Jenabatteries GmbH | Redox-Flow-Zelle zur Speicherung elektrischer Energie |
| EP2884969A1 (en) * | 2012-08-15 | 2015-06-24 | Dow Corning Corporation | Multi - layer transdermal drug delivery system |
| WO2014111790A2 (en) * | 2013-01-15 | 2014-07-24 | Zydus Technologies Limited | Stable transdermal pharmaceutical drug delivery system comprising rivastigmine |
| US20240082065A1 (en) * | 2016-07-08 | 2024-03-14 | Moteah Williams | Waterproof and transparent wound barrier and method of manufacturing same |
| WO2018038022A1 (ja) | 2016-08-22 | 2018-03-01 | 救急薬品工業株式会社 | 貼付剤 |
| US20210085633A1 (en) * | 2017-07-19 | 2021-03-25 | Teikoku Seiyaku Co., Ltd. | Rivastigmine-containing transdermal absorption preparation |
| DE102018120505A1 (de) * | 2017-10-20 | 2019-04-25 | Amw Gmbh | Verhinderung der Kristallisation von Wirkstoffen in transdermalen Darreichungssystemen |
| DE102017127433A1 (de) * | 2017-11-21 | 2019-05-23 | Lts Lohmann Therapie-Systeme Ag | TTS auf Basis von klebenden Weichmacher-Polymer-Matrices |
| WO2019175109A1 (en) * | 2018-03-13 | 2019-09-19 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system comprising a silicone acrylic hybrid polymer |
| JP7170285B2 (ja) * | 2018-05-17 | 2022-11-14 | パナソニックＩｐマネジメント株式会社 | 生体貼付け用選択透過膜、経皮吸収キットおよび美容方法 |
| EP3871877A1 (en) | 2018-08-08 | 2021-09-01 | Danapak Flexibles A/S | Improved films and laminates for use in packaging reactive compounds |
| KR20200025883A (ko) | 2018-08-31 | 2020-03-10 | 에스케이케미칼 주식회사 | 장기 투여용 리바스티그민 패취 |
| KR102710072B1 (ko) | 2018-08-31 | 2024-09-24 | 에스케이케미칼 주식회사 | 장기 투여용 리바스티그민 패취 |
| BR112021023509A2 (pt) * | 2019-07-09 | 2022-01-18 | Lts Lohmann Therapie Systeme Ag | Sistema terapêutico transdérmico compreendendo uma camada contendo o agente ativo compreendendo um polímero acrílico e uma camada de contato com a pele compreendendo um adesivo de gel de silicone |
| CN113616625B (zh) * | 2021-08-26 | 2023-05-30 | 大连科翔科技开发有限公司 | 一种卡巴拉汀的长效透皮贴剂 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU201906B (en) | 1987-03-04 | 1991-01-28 | Sandoz Ag | Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them |
| AU3247193A (en) * | 1992-08-25 | 1994-03-15 | Cygnus Therapeutic Systems | Printed transdermal drug delivery device |
| JPH0912448A (ja) * | 1995-04-28 | 1997-01-14 | Read Chem Kk | 薬物放出制御型経皮吸収製剤 |
| GB9800526D0 (en) | 1998-01-12 | 1998-03-11 | Ciba Geigy Ag | Organic compounds |
| US6348210B1 (en) * | 1998-11-13 | 2002-02-19 | Alza Corporation | Methods for transdermal drug administration |
| DE19918106A1 (de) | 1999-04-22 | 2000-10-26 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern |
| DE10033853A1 (de) | 2000-07-12 | 2002-01-31 | Hexal Ag | Transdermales therapeutisches System mit hochdispersem Siliziumdioxid |
| DE10103860B4 (de) * | 2001-01-30 | 2004-12-23 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung |
| DE10141652B4 (de) | 2001-08-24 | 2011-04-07 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung |
| DE10141650C1 (de) * | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
| CN101146523B (zh) * | 2004-10-21 | 2010-12-29 | 杜雷科特公司 | 透皮给药系统 |
| US8252319B2 (en) * | 2004-10-21 | 2012-08-28 | Durect Corporation | Transdermal delivery system for sufentanil |
| TWI389709B (zh) * | 2005-12-01 | 2013-03-21 | Novartis Ag | 經皮治療系統 |
| CA2634975A1 (en) * | 2005-12-30 | 2007-07-12 | Coloplast A/S | A layered adhesive construct having a mouldable layer as skin contact surface |
| CN101304735A (zh) * | 2006-01-12 | 2008-11-12 | Lts勒曼治疗系统股份公司 | 用于挥发性和/或热不稳定的物质的经皮治疗体系 |
| NZ572809A (en) * | 2006-05-08 | 2011-02-25 | Teikoku Seiyaku Kk | Transdermally absorbable preparation comprising anti-dementia agent |
| US9248104B2 (en) | 2006-08-17 | 2016-02-02 | Core Tech Solutions, Inc. | Transdermal methods and systems for treating Alzheimer's disease |
| DE102006054731B4 (de) * | 2006-11-21 | 2013-02-28 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie |
| WO2009009651A1 (en) * | 2007-07-10 | 2009-01-15 | Agile Therapeutics, Inc. | Dermal delivery device with ultrasonic weld |
| WO2009026135A2 (en) | 2007-08-17 | 2009-02-26 | Alza Corporation | Controlled transdermal bisoprolol delivery system |
| WO2009107478A1 (ja) * | 2008-02-27 | 2009-09-03 | 久光製薬株式会社 | 貼付剤及び包装体 |
| US20090291127A1 (en) * | 2008-05-21 | 2009-11-26 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
| JP2010126450A (ja) * | 2008-11-25 | 2010-06-10 | Lintec Corp | 経皮吸収貼付剤 |
| ES2670227T3 (es) * | 2009-12-22 | 2018-05-29 | Luye Pharma Ag | Sistema terapéutico transdérmico para la administración de rivastigmina o sus derivados |
-
2010
- 2010-12-14 PT PT101949683T patent/PT2468274E/pt unknown
- 2010-12-14 DK DK10194968.3T patent/DK2468274T3/en active
- 2010-12-14 RS RS20150562A patent/RS54173B1/en unknown
- 2010-12-14 HU HUE10194968A patent/HUE027916T2/en unknown
- 2010-12-14 EP EP10194968.3A patent/EP2468274B1/de active Active
- 2010-12-14 SI SI201031006T patent/SI2468274T1/sl unknown
- 2010-12-14 PL PL10194968T patent/PL2468274T3/pl unknown
- 2010-12-14 ES ES10194968.3T patent/ES2545094T3/es active Active
-
2011
- 2011-12-14 EA EA201300704A patent/EA026520B1/ru not_active IP Right Cessation
- 2011-12-14 PT PT117994137T patent/PT2651410T/pt unknown
- 2011-12-14 MY MYPI2013001975A patent/MY183873A/en unknown
- 2011-12-14 BR BR112013014616-8A patent/BR112013014616B1/pt active IP Right Grant
- 2011-12-14 WO PCT/EP2011/072812 patent/WO2012080365A1/de active Application Filing
- 2011-12-14 KR KR1020137016047A patent/KR101842309B1/ko active IP Right Grant
- 2011-12-14 EP EP11799413.7A patent/EP2651410B1/de active Active
- 2011-12-14 JP JP2013543774A patent/JP6043296B2/ja active Active
- 2011-12-14 CN CN202110438860.3A patent/CN113244199A/zh active Pending
- 2011-12-14 CN CN201180059614.1A patent/CN103269698B/zh active Active
- 2011-12-14 PL PL11799413T patent/PL2651410T3/pl unknown
- 2011-12-14 DK DK11799413.7T patent/DK2651410T3/da active
- 2011-12-14 RS RS20201478A patent/RS61155B1/sr unknown
- 2011-12-14 LT LTEP11799413.7T patent/LT2651410T/lt unknown
- 2011-12-14 AU AU2011343363A patent/AU2011343363B2/en active Active
- 2011-12-14 SI SI201131933T patent/SI2651410T1/sl unknown
- 2011-12-14 HU HUE11799413A patent/HUE052137T2/hu unknown
- 2011-12-14 US US13/994,242 patent/US10660863B2/en active Active
- 2011-12-14 MX MX2013005581A patent/MX345344B/es active IP Right Grant
- 2011-12-14 CN CN201710451001.1A patent/CN107412202A/zh active Pending
- 2011-12-14 CA CA2817461A patent/CA2817461C/en active Active
- 2011-12-14 ES ES11799413T patent/ES2836483T3/es active Active
- 2011-12-14 CA CA3065240A patent/CA3065240C/en active Active
-
2013
- 2013-05-30 ZA ZA2013/03965A patent/ZA201303965B/en unknown
-
2015
- 2015-07-31 SM SM201500184T patent/SMT201500184B/xx unknown
- 2015-08-19 HR HRP20150881TT patent/HRP20150881T1/hr unknown
- 2015-08-25 CY CY20151100738T patent/CY1116638T1/el unknown
-
2017
- 2017-08-11 AU AU2017213569A patent/AU2017213569B2/en active Active
-
2018
- 2018-02-28 HK HK18102858.7A patent/HK1243336A1/zh unknown
-
2020
- 2020-04-28 US US16/860,210 patent/US20200289426A1/en not_active Abandoned
- 2020-11-25 CY CY20201101121T patent/CY1123712T1/el unknown
- 2020-11-26 HR HRP20201880TT patent/HRP20201880T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2013005581A (es) | Sistema terapeutico transdermico para la administracion de una sustancia activa. | |
| MY163809A (en) | Transdermal drug delivery system containing donepezil | |
| IN2012DN01225A (es) | ||
| MX2009012273A (es) | Dispositivos de suministro transd?rmico que aseguran la liberaci?n mejorada de un principio activo a trav?s de una interfaz biol?gica. | |
| WO2011076621A3 (de) | Transdermales therapeutisches system zur verabreichung von rivastigmin oder dessen derivaten | |
| WO2012124966A3 (ko) | 펜타닐 경피 패치제 | |
| BR112012024835A2 (pt) | adesivo de distribuição transdérmica | |
| WO2011022199A8 (en) | Multi-layer transdermal patch | |
| UA114101C2 (xx) | Трансдермальна терапевтична система для введення фентанілу або його аналога | |
| NZ611920A (en) | Percutaneous absorption preparation containing rivastigmine | |
| WO2014028396A3 (en) | Therapeutic elastic tape | |
| BR112012001349B8 (pt) | processo livre de solvente para produzir uma composição adesiva | |
| MX2012008381A (es) | Tira dental para administracion de tratamiento oral. | |
| NZ709521A (en) | Transdermal dosage form for low-melting point active agent | |
| MX351514B (es) | Sistema terapeutico transdermico para clorhidrato de acido 5-aminolevulinico. | |
| EA201300648A1 (ru) | Трансдермальная терапевтическая система (tts), содержащая ротиготин | |
| WO2010111533A3 (en) | Transdermal delivery of pkc modulatory peptides through microporated skin | |
| NZ595549A (en) | Transdermal therapeutic system containing nicotine | |
| WO2011066970A3 (de) | Transdermales therapeutisches system für die verabreichung von peptiden | |
| IN2014CN02984A (es) | ||
| WO2012111996A3 (ko) | 갈란타민 또는 그의 염을 함유하는 경피흡수제제 | |
| WO2016149077A3 (en) | Fentanyl transdermal delivery system | |
| MX2015010967A (es) | Formulaciones transdermicas de laquinimod. | |
| EA201490390A1 (ru) | Вспомогательное средство для накладывания | |
| WO2012009640A3 (en) | B cell depletion for central nervous system injuries and methods and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |